Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin.

Zarebkohan A, Najafi F, Moghimi HR, Hemmati M, Deevband MR, Kazemi B.

Iran J Pharm Res. 2016 Fall;15(4):629-640.

2.

A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.

Lu J, Burnett MG, Shpak M.

Cancer Genomics Proteomics. 2016 11-12;13(6):467-474.

3.

Increased Default Mode Network Connectivity in Individuals at High Familial Risk for Depression.

Posner J, Cha J, Wang Z, Talati A, Warner V, Gerber A, Peterson BS, Weissman M.

Neuropsychopharmacology. 2016 Jun;41(7):1759-67. doi: 10.1038/npp.2015.342. Epub 2015 Nov 23.

4.

New insights into the genetics of glioblastoma multiforme by familial exome sequencing.

Backes C, Harz C, Fischer U, Schmitt J, Ludwig N, Petersen BS, Mueller SC, Kim YJ, Wolf NM, Katus HA, Meder B, Furtwängler R, Franke A, Bohle R, Henn W, Graf N, Keller A, Meese E.

Oncotarget. 2015 Mar 20;6(8):5918-31.

5.

Discriminating risk and resilience endophenotypes from lifetime illness effects in familial major depressive disorder.

Peterson BS, Wang Z, Horga G, Warner V, Rutherford B, Klahr KW, Graniello B, Wickramaratne P, Garcia F, Yu S, Hao X, Adams PB, Qian M, Liu J, Gerber A, Weissman MM.

JAMA Psychiatry. 2014 Feb;71(2):136-48. doi: 10.1001/jamapsychiatry.2013.4048.

6.

Nationwide registry-based analysis of cancer clustering detects strong familial occurrence of Kaposi sarcoma.

Kaasinen E, Aavikko M, Vahteristo P, Patama T, Li Y, Saarinen S, Kilpivaara O, Pitkänen E, Knekt P, Laaksonen M, Artama M, Lehtonen R, Aaltonen LA, Pukkala E.

PLoS One. 2013;8(1):e55209. doi: 10.1371/journal.pone.0055209. Epub 2013 Jan 24.

7.

Association study of xenobiotic detoxication and repair genes with malignant brain tumors in children.

Salnikova LE, Zelinskaya NI, Belopolskaya OB, Aslanyan MM, Rubanovich AV.

Acta Naturae. 2010 Oct;2(4):58-65.

8.

Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site.

Albright F, Teerlink C, Werner TL, Cannon-Albright LA.

BMC Cancer. 2012 Apr 3;12:138. doi: 10.1186/1471-2407-12-138. Review.

9.

Familial glioblastoma: A case report of glioblastoma in two brothers and review of literature.

Ugonabo I, Bassily N, Beier A, Yeung JT, Hitchcock L, De Mattia F, Karim A.

Surg Neurol Int. 2011;2:153. doi: 10.4103/2152-7806.86833. Epub 2011 Oct 29.

10.

Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas.

Liu W, Lv G, Li Y, Li L, Wang B.

J Exp Clin Cancer Res. 2011 Aug 15;30:76. doi: 10.1186/1756-9966-30-76.

11.

Familial risks in nervous system tumours: joint Nordic study.

Hemminki K, Tretli S, Olsen JH, Tryggvadottir L, Pukkala E, Sundquist J, Granström C.

Br J Cancer. 2010 Jun 8;102(12):1786-90. doi: 10.1038/sj.bjc.6605708. Epub 2010 May 25.

12.

Inherited predisposition to glioma.

Kyritsis AP, Bondy ML, Rao JS, Sioka C.

Neuro Oncol. 2010 Jan;12(1):104-13. doi: 10.1093/neuonc/nop011. Epub 2009 Nov 23. Review.

13.

Advances in the genetics of glioblastoma: are we reaching critical mass?

Purow B, Schiff D.

Nat Rev Neurol. 2009 Aug;5(8):419-26. doi: 10.1038/nrneurol.2009.96. Epub 2009 Jul 14. Review.

Supplemental Content

Support Center